Nelson Cruz likely to accept suspension, leaves Biogenesis-tainted agents

21 Comments

The word Wednesday was that Nelson Cruz might appeal the anticipated 50-game ban handed coming down in the Biogenesis scandal, but Jon Heyman reports that Cruz has decided to serve his time now in anticipation of becoming a free agent this winter.

It was also disclosed that Cruz is leaving the ACES agency, which represented several players expected to get Biogenesis suspensions. Yahoo! Sports’ Jeff Passan says he’s signing on with Adam Katz.

By serving the suspension now, Cruz, who is hitting .269/.330/.511 with 27 homers and 76 RBI, will certainly be a more attractive free agent this winter. Of course, teams will still be wondering how much of his bounce-back season this year was due to PED usage, even though his acquisition of Biogenesis drugs took place last year, when his rate numbers were the worst they’ve been since 2007. Or perhaps he’s simply been cheating all along.

Cruz is also bailing on the Rangers when they dearly need his bat in the middle of the order. Speculation last week was that they felt a less urgent need to trade for an outfielder because they thought he was going to appeal the suspension. The Rangers may welcome Cruz back for the postseason anyway, should they get there, but they probably will opt to go in a different direction this winter.

As for the agent switch, well, it’s no wonder than Cruz wanted to get away from ACES, which formerly represented Melky Cabrera when he was suspended and also handles Biogenesis-connected players Jhonny Peralta, Gio Gonzalez, Jesus Montero. Fautino De Los Santos and Cesar Puello, according to MLBTR’s agency database. The Brooklyn-based agency, run by brothers Seth and Sam Levinson, is or at least was being investigated by MLB for links to Biogenesis.

Update: The new names revealed in the Biogenesis scandal today — Antonio Bastardo, Sergio Escalona and Jordany Valdespin — are all ACES clients as well.

Carlos Martínez underwent ‘small procedure’ on right shoulder

David J. Griffin/Icon Sportswire via Getty Images
Leave a comment

Cardinals president of baseball operations John Mozeliak confirmed on Sunday, to KMOX/1120 AM and StlToday.com, that pitcher Carlos Martínez underwent a “small procedure” to address discomfort in his right shoulder and encourage healing as well as a platelet-rich plasma injection.

Martínez, 28, began experiencing shoulder issues in 2018 which impacted his ability to pitch deep into games. Upon his return from the injured list in late August that year, the club moved him into the bullpen. He remained in the bullpen for 2019, making his season debut in May, and had a successful year, racking up 24 saves with a 3.17 ERA and a 53/18 K/BB ratio in 48 1/3 innings.

Martínez wants to start again and the Cardinals have said they will afford him the opportunity. He is expected to be on track to participate in spring training as usual.